Table 2.
Immune biomarker concentrations
| Control (n=34) |
All PLWH (n=75) |
Virally Suppressed PLWH (n=54) |
Non-Suppressed PLWH (n=18) |
|
|---|---|---|---|---|
| LBP (ng/ml) | 10027 (7131, 14491) | 13998 (7857, 20851) | 14893 (7856, 22003) | 12588 (6451, 17515) |
| LPS (pg/ml) | 79 (60, 135) | 98 (70, 137) | 102 (70, 141) | 86 (69, 126) |
| sCD14 (ng/ml) | 1639 (1471, 1847) | 2081 (1667, 2478) | 2119 (1766, 2552) | 1967 (1639, 2308) |
| sCD163 (ng/ml) | 399 (275, 493) | 620 (390, 851) | 606 (419, 770) | 740 (375, 1267) |
Values are reported as median (interquartile range)
Note: n’s indicate the number of individuals in each group, with each individual contributing 1–3 plasma samples. Details on sample size are as follows: controls, 51 samples from 34 individuals; all PLWH, 116 samples from 75 individuals; suppressed PLWH, 85 samples from 54 individuals; non-suppressed PLWH, 27 samples from 18 individuals. Data on viral load were missing for 3 individuals.